Last reviewed · How we verify

Hexavalent vaccine

International Centre for Diarrhoeal Disease Research, Bangladesh · FDA-approved active Biologic

Hexavalent vaccine is a vaccine Biologic drug developed by International Centre for Diarrhoeal Disease Research, Bangladesh. It is currently FDA-approved for Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children. Also known as: Diphtheria, tetanus, pertussis, hepatitis B,, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed)., HEXASIIL.

A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens.

A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens. Used for Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children.

At a glance

Generic nameHexavalent vaccine
Also known asDiphtheria, tetanus, pertussis, hepatitis B,, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed)., HEXASIIL
SponsorInternational Centre for Diarrhoeal Disease Research, Bangladesh
Drug classvaccine
ModalityBiologic
Therapeutic areaImmunology
PhaseFDA-approved

Mechanism of action

Hexavalent vaccines typically combine immunogens against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b. The vaccine works by presenting inactivated or attenuated antigens that trigger both humoral (antibody) and cell-mediated immune responses, conferring protection against these six diseases with a single injection. This combination approach improves vaccination compliance and reduces the number of injections needed in pediatric immunization schedules.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hexavalent vaccine

What is Hexavalent vaccine?

Hexavalent vaccine is a vaccine drug developed by International Centre for Diarrhoeal Disease Research, Bangladesh, indicated for Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children.

How does Hexavalent vaccine work?

A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens.

What is Hexavalent vaccine used for?

Hexavalent vaccine is indicated for Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children.

Who makes Hexavalent vaccine?

Hexavalent vaccine is developed and marketed by International Centre for Diarrhoeal Disease Research, Bangladesh (see full International Centre for Diarrhoeal Disease Research, Bangladesh pipeline at /company/international-centre-for-diarrhoeal-disease-research-bangladesh).

Is Hexavalent vaccine also known as anything else?

Hexavalent vaccine is also known as Diphtheria, tetanus, pertussis, hepatitis B,, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed)., HEXASIIL.

What drug class is Hexavalent vaccine in?

Hexavalent vaccine belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is Hexavalent vaccine in?

Hexavalent vaccine is FDA-approved (marketed).

What are the side effects of Hexavalent vaccine?

Common side effects of Hexavalent vaccine include Injection site pain, redness, or swelling, Fever, Irritability or fussiness, Drowsiness, Loss of appetite.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing